Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.44 USD | +1.90% | +9.15% | +27.52% |
15/05 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
09/05 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.52% | 789M | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.67% | 21.97B | |
-4.64% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024